# A.yaml - 基本情報
ticker: RZLV
name: "Rezolve Ai"
sector: "Technology (AI/Commerce)"
currency: USD
fye_month: 12
default_wacc: 0.12

# T1逐語反映（Core①②③）
# 要件: 逐語は各≤40語（必ず本文から。見出し/索引/目次の文言抜粋は不可）
t1_facts:
  core_1_growth:
    - "[2025-05-29][T1-P][Core①] \"expects to exceed $100 million ARR by year-end; locked in $70 million ARR.\" (impact: ARR_kpi)"
    - "[2025-07-24][T1-K][Core①] \"Private placement pricing (20,000,000 shares @ $2.50)\" (impact: private_placement, accession: 000095017025098147)"
    - "[2025-07-25][T1-K][Core①] \"PIPE Financing closed on July 25, 2025\" (impact: pipe_closing, accession: 000095017025098790)"
    - "ARR実数 $70M（as of 2025-05-29, T1-P）。定義＝「サブスクリプション契約の時点年率化」"
    - "Liverpool と年額 $9.8M の大型契約を発表"
    - "Citadel Global Equities主導の$50M戦略投資を発表（構造はクリーン・エクイティ示唆）"
  core_2_quality:
    - "[2025-04-23][T1-F][Core②] \"Revenue is recognized when control transfers...\" (impact: revrec_bridge, accession: 000119312524151740)"
    - "[2025-04-23][T1-F][Core②] \"Ordinary shares issued and outstanding ... 208,349,697.\" (impact: dilution_base, accession: 000119312524151740)"
    - "[2025-07-29][T1-P][Core②] \"basic shares 235,349,697 as of Jul 29, 2025.\" (impact: dilution_base, accession: 000119312525164453)"
    - "IFRS/RevRec：「支配が移転したとき収益計上」（T1-F, 20-F Note 2）"
    - "売上：TTM $15.28M（FY2024, 20-F）。Q1'25 $2.75M → Q2'25 $8.75M（6-K, H1'25= $11.5M）"
    - "繰延収益：流動 $10.54M／非流動 $2.13M（FY2024, 20-F）"
    - "顧客集中：Top1=25%（20-F 注記）"
    - "発行済株式：235,349,697（2025-07-29時点, T1-P）。ワラント計 25,350,000（潜在希薄化 ≈12.2%）"
  core_3_timing:
    - "[2025-09-02][T1-P][Time] \"will release H1 2025 results on Oct 1, 2025.\" (impact: scheduling)"
    - "[2025-06-12][T1-K][Time] \"Notice under Nasdaq Rule 5550(a)(2); 180-day cure to Dec 9, 2025.\" (impact: listing, accession: 000119312525143211)"
    - "[2025-09-09][T1-K][Core③] \"General Meeting notice (Sept 30, 2025)\" (impact: gm_notice, accession: 000119312525199280)"
    - "[2025-08-29][T1-P][Time] \"EGM approved reverse split 1-for-2 to 1-for-100; not yet effected.\" (impact: option_to_cure)"
    - "H1'25 決算発表：2025-10-01（会社IR発表, T1-P）。〔Time〕ここでARR→売上の橋渡しの開示有無が分岐"
    - "2025/07/24付 Form 6-K（資金調達関連の書類添付や配置）"
    - "[2024-05-29][T1-F][Core③] \"The name of the Company was changed from 'Armada Acquisition Corp. I' to 'Rezolve AI Corp.'\" (impact: capital_structure, accession: 000119312524151740)"

# 基本財務情報（T1実績）
fundamentals:
  arr_current: "$70M"  # 2025-05-29時点（T1-P）
  arr_target: "$100M"  # 年内目標（T1-P）
  revenue_ttm: "$15.28M"  # FY2024（20-F）
  revenue_q1_25: "$2.75M"  # Q1'25
  revenue_q2_25: "$8.75M"  # Q2'25
  revenue_h1_25: "$11.5M"  # H1'25合計
  deferred_revenue_current: "$10.54M"  # 流動
  deferred_revenue_noncurrent: "$2.13M"  # 非流動
  customer_concentration: "Top1=25%"  # 20-F注記
  shares_outstanding: "235,349,697"  # 2025-07-29時点（T1-P）
  warrants: "25,350,000"  # 潜在希薄化≈12.2%

# PIPE私募（T1確定）
private_placement:
  pricing_date: "2025-07-24"  # T1-K
  price_per_share: "$2.50"  # T1-K
  shares_issued: "20,000,000"  # T1-K
  closing_date: "2025-07-25"  # T1-K確定
  post_pp_shares: "235,349,697"  # 2025-07-29時点（T1-P確定）

# 上場維持×希薄化イベント
listing_compliance:
  deficiency_notice:
    rule: "Nasdaq Listing Rule 5550(a)(2)"
    notice_date: "2025-06-10"
    cure_deadline: "2025-12-09"
    requirement: "Bid≧$1要件"
    remediation: "10連続営業日達成 or 逆分割等での是正"
    excerpt: "Company has 180 days to regain compliance; will monitor bid and may consider reverse split."
  reverse_split_authorization:
    ratio_range: "1-for-2 up to 1-for-100"
    approval_date: "2025-08-28"
    status: "株主総会可決済み"
  reverse_split_implementation:
    status: "未実施"
    as_of: "2025-08-29"
    note: "EGM approved reverse split 1-for-2 to 1-for-100; not yet effected"
  
# T1確定分（判明事項）
t1_confirmed:
  listing_compliance:
    - "Nasdaq最小気配値の欠陥通知：Rule 5550(a)(2)、通知 2025-06-10、是正期限 2025-12-09"
    - "逆分割の権限承認：1-for-2〜1-for-100（実施は未確認）"
  capital_structure:
    - "発行済株式（基準点）：215,349,697"
    - "私募の成立：2,000万株 @ $2.50＝約$50M"
  financial_metrics:
    - "ARR実数：$70M（as of 2025-05-29）・定義明示あり"
    - "売上：FY2024 TTM $15.28M、H1'25 $11.5M（Q1 $2.75M／Q2 $8.75M）"
    - "繰延収益（FY2024末）：流動 $10.54M／非流動 $2.13M"
  accounting_risk:
    - "会計基準：IFRS、Going Concernの重大な不確実性"
    - "顧客集中：Top1 25%"
    - "ワラント：合計 25,350,000、行使価額 $11.5、初回行使 2024-09-14、満期 2029-08-15"

# 未判明／未確定（T1で空欄 or 要追加確認）
t1_uncertain:
  deficiency_notice_excerpt:
    status: "未取得"
    issue: "該当6-Kの本文抜粋（≤40語）の取得テキストが未貼付"
    note: "URL・日付は特定済み"
  post_pp_shares:
    status: "未確定"
    issue: "T1-Pでは 235,349,697（2025-07-29）を示唆するが、T1-K/Fでの確定記載は未捕捉"
  reverse_split_implementation:
    status: "未確認"
    issue: "比率・発効日のT1は未確認（承認のみ）"
  compliance_governance:
    status: "検出ゼロ"
    items:
      - "Non-reliance / Restatement / 監査人交代：該当T1なし"
      - "RevRec変更・当局調査・重大訴訟更新：該当T1なし"
  arr_gaap_bridge:
    status: "未取得"
    issue: "ARR↔GAAP売上の橋渡し定量：ロールフォワード等のT1表は未取得"

# リスク指標
risk_metrics:
  ap_connected: false  # AP未接続
  valuation_status: "保留"

# Time Annotation（AHF〔Time〕要件）
time_annotation:
  primary_time_event:
    event_date: "2025-12-09"
    event_title: "Nasdaq Listing Rule 5550(a)(2) Cure Deadline"
    event_type: "Compliance Deadline"
    requirement: "Bid≧$1要件の是正期限"
    t1_source: "T1-K"
    t1_url: "https://www.sec.gov/Archives/edgar/data/1920294/000119312525143211/d775122d6k.htm"
    window_quarters: "180日間の是正期間"
    delta_t: "2025-12-09 - 2025-06-10 = 180日間の是正期間"
  secondary_time_events:
    earnings_schedule:
      event_date: "2025-10-01"
      event_title: "Rezolve Ai to release H1 2025 results before market open"
      event_type: "Earnings Release"
      conference_call: "8:30 AM ET"
      announcement_source: "Press Release (Investors)"
      t1_source: "T1-P"
      t1_url: "https://rezolve.com/investors/rezolve-ai-to-announce-strong-first-half-2025-results-and-accelerated-growth-momentum/"
      window_quarters: "H1 2025"
      delta_t: "2025-10-01 - 2025-09-02 = 29日間の予告期間"